Extracellular vesicles shed by follicular lymphoma B cells promote polarization of the bone marrow stromal cell niche.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
08 07 2021
Historique:
received: 26 08 2020
accepted: 08 02 2021
pubmed: 22 4 2021
medline: 31 7 2021
entrez: 21 4 2021
Statut: ppublish

Résumé

Follicular lymphoma (FL) originates in the lymph nodes (LNs) and infiltrates bone marrow (BM) early in the course of the disease. BM FL B cells are characterized by a lower cytological grade, decreased proliferation, and a specific phenotypic and subclonal profile. Mesenchymal stromal cells (MSCs) obtained from FL BM display a specific gene expression profile (GEP), including enrichment for a lymphoid stromal cell signature, and an increased capacity to sustain FL B-cell growth. However, the mechanisms triggering the formation of the medullar FL permissive stromal niche have not been identified. In the current work, we demonstrate that FL B cells produce extracellular vesicles (EVs) that can be internalized by BM-MSCs, making them more efficient to support FL B-cell survival and quiescence. Accordingly, EVs purified from FL BM plasma activate transforming growth factor β-dependent and independent pathways in BM-MSCs and modify their GEP, triggering an upregulation of factors classically associated with hematopoietic stem cell niche, including CXCL12 and angiopoietin-1. Moreover, we provide the first characterization of BM FL B-cell GEP, allowing the definition of the landscape of molecular interactions they could engage with EV-primed BM-MSCs. This work identifies FL-derived EVs as putative mediators of BM stroma polarization and supports further investigation of their clinical interest for targeting the crosstalk between BM-MSCs and malignant B cells.

Identifiants

pubmed: 33881493
pii: S0006-4971(21)00427-4
doi: 10.1182/blood.2020008791
doi:

Substances chimiques

Lymphotoxin alpha1, beta2 Heterotrimer 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-70

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 by The American Society of Hematology.

Auteurs

Erwan Dumontet (E)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.
Department of Biology, Rennes University Hospital, Rennes, France.

Céline Pangault (C)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.
Department of Biology, Rennes University Hospital, Rennes, France.

David Roulois (D)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.

Matthis Desoteux (M)

UMRS 1242 Chemistry Oncogenesis Stress Signaling, INSERM, University of Rennes, Centre de Lutte contre le Cancer Eugène Marquis, Rennes, France.

Simon Léonard (S)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.

Tony Marchand (T)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.
Department of Hematology, Rennes University Hospital, Rennes, France.

Maelle Latour (M)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.
Department of Biology, Rennes University Hospital, Rennes, France.

Patricia Legoix (P)

Institut Curie Genomics of Excellence Platform and.

Damarys Loew (D)

Laboratoire de Spectrométrie de Masse Protéomique, Institut Curie Research Center, Paris Sciences et Lettres (PSL) University, Paris, France.

Florent Dingli (F)

Laboratoire de Spectrométrie de Masse Protéomique, Institut Curie Research Center, Paris Sciences et Lettres (PSL) University, Paris, France.

Joelle Dulong (J)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.
Department of Biology, Rennes University Hospital, Rennes, France.

Erwan Flecher (E)

Department of Thoracic and Cardiac Surgery, Rennes University Hospital, Rennes, France; and.

Cédric Coulouarn (C)

UMRS 1242 Chemistry Oncogenesis Stress Signaling, INSERM, University of Rennes, Centre de Lutte contre le Cancer Eugène Marquis, Rennes, France.

Guillaume Cartron (G)

Department of Hematology, Montpellier University Hospital, Montpellier, France.

Thierry Fest (T)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.
Department of Biology, Rennes University Hospital, Rennes, France.

Karin Tarte (K)

Unité Mixte de Recherche (UMR) 1236, INSERM, Université Rennes, EFS Bretagne, Laboratoires d'Excellence "Immunotherapy-Graft-Oncology" (LabEx IGO), Rennes, France.
Department of Biology, Rennes University Hospital, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH